Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 12, 2004, Pages 2271-2276

  Ferreccio, Catterina ^a,g   Prado, Rodrigo B ^b   Luzoro, Amaranta V ^b   Ampuero, Sandra Ll ^b   Snijders, Peter J F ^c   Meijer, Chris J L M ^c   Vaccarella, Salvatore V ^d   Jara, Alejandro T ^a   Puschel, Klaus I ^a   Robles, Sylvia C ^e   Herrero, Rolando ^d,f   Franceschi, Silvia F ^d   Ojeda, Jose M ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e PAN AMERICAN HEALTH ORGANIZATION   (United States)

^f Proyecto Epidemiologico Guanacaste   (Costa Rica)

^g PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER RISK; CENTRAL AMERICA; CHILE; FEMALE; HUMAN; HUMAN TISSUE; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEXUALITY; SOUTH AMERICA; UTERINE CERVIX CANCER; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILE; DNA, VIRAL; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 19944428433     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. IARC. Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Vol. 64. Lyon (France): IARC; 1995.
2. Jacobs MV, Walboomers JMM, Sneijders PJF, et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000;87:221-7.
3. Jacobs MV, Snijders PJ, van den Brule AJ, et al. A general primer GP5+GP6 (+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997;35:791-5.
4. Walboomers JWW, Melkert P, van den Brule AJC, et al. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix: In: Herrington CS, McGee O, editors. Diagnostic molecular pathology: a practical approach. Oxford: Oxford University Press; 1992. p. 152-72.
5. Jacobs MV, de Roda Husman AM, van den Brule AJC, et al. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33:901-5.
6. Muñoz N, Bosh FX, Sanjosé S, Herrero R, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
7. Rossenberg PS, Katki H, Swanson CA, Brown LM, Wacholder S, Hoover RN. Quantifying epidemiologic risk factors using non-parametric regression: model selection remains the greatest challenge. Stat Med 2003;22:3369-81.
8. Wood SN. Modeling and smoothing parameter estimation with multiple quadratic penalties. J R Stat Soc B 2000;62:413-28.
9. Lazcano-Ponce E, Herrero R, Muñoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-20.
10. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Int 2000;92:464-74.
11. Molano M, Posso H, Weiderpass E, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87:324-33.
12. Sanjosé S, Alnirall R, Lloveras B, et al. Cervical human papillomavirus infections in the female population in Barcelona, Spain. Sex Transm Dis 2003;30:788-93.
13. Anh PTH, Hieu NT, Herrero R, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003;104:213-20.
14. Sukvirach S, Smith JS, Tunsakul S, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003;187:1246-56.
15. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
16. Bauer HM, Hildesheim A, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993;20:274-8.
17. Kjaer SK, van den Brule AJC, Bock JE, et al. Determinants of genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal PAP smear: are there different risk profiles for oncogenic and non oncogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997;6:799-805.
18. Burk RD, Kelly P, Feldman J, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996;23:333-41.
19. Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cervical human Papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 1995;172:756-63.
20. Shin H-R, Lee D-H, Herrero R, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003;103:413-21.